| Literature DB >> 27112289 |
Sara B E Andersson1, Caroline Alvebratt1, Jan Bevernage2, Damien Bonneau3, Claudia da Costa Mathews4, Rikesh Dattani5, Khadijah Edueng1, Yan He6, René Holm7, Cecilie Madsen8, Thomas Müller9, Uwe Muenster10, Anette Müllertz8, Krista Ojala11, Thomas Rades8, Peter Sieger12, Christel A S Bergström13.
Abstract
The purpose of this study was to investigate the interlaboratory variability in determination of apparent solubility (Sapp) and intrinsic dissolution rate (IDR) using a miniaturized dissolution instrument. Three poorly water-soluble compounds were selected as reference compounds and measured at multiple laboratories using the same experimental protocol. Dissolution was studied in fasted-state simulated intestinal fluid and phosphate buffer (pH 6.5). An additional 6 compounds were used for the development of an IDR measurement guide, which was then validated with 5 compounds. The results clearly showed a need for a standardized protocol including both the experimental assay and the data analysis. Standardization at both these levels decreased the interlaboratory variability. The results also illustrated the difficulties in performing disc IDR on poorly water-soluble drugs because the concentrations reached are typically below the limit of detection. The following guidelines were established: for compounds with Sapp >1 mg/mL, the disc method is recommended. For compounds with Sapp <100 μg/mL, IDR is recommended to be performed using powder dissolution. Compounds in the interval 100 μg/mL to 1 mg/mL can be analyzed with either of these methods.Entities:
Keywords: apparent solubility; dissolution; intrinsic dissolution rate; poorly water-soluble drug; preformulation; small scale
Mesh:
Substances:
Year: 2016 PMID: 27112289 DOI: 10.1016/j.xphs.2016.03.010
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.534